Abstract

Pneumonia is a leading cause of death in children and the elderly worldwide, accounting for 15% of all deaths of children under 5 years old. Streptococcus pneumoniae is a common and aggressive cause of pneumonia and can also contribute to meningitis and sepsis. Despite the widespread use of antibiotics, mortality rates for pneumonia remain unacceptably high in part due to the release of bacterial toxins. Pneumolysin (PLY) is a cholesterol-dependent toxin that is produced by Streptococcus, and it is both necessary and sufficient for the development of the extensive pulmonary permeability edema that underlies acute lung injury. The mechanisms by which PLY disrupts the pulmonary endothelial barrier are not fully understood. Previously, we found that reactive oxygen species (ROS) contribute to the barrier destructive effects of PLY and identified an unexpected but potent role of Hsp70 in suppressing ROS production. The ability of Hsp70 to influence PLY-induced barrier dysfunction is not yet described, and the goal of the current study was to identify whether Hsp70 upregulation is an effective strategy to protect the lung microvascular endothelial barrier from G+ bacterial toxins. Overexpression of Hsp70 via adenovirus-mediated gene transfer attenuated PLY-induced increases in permeability in human lung microvascular endothelial cells (HLMVEC) with no evidence of cytotoxicity. To adopt a more translational approach, we employed a pharmacological approach using geranylgeranylacetone (GGA) to acutely upregulate endogenous Hsp70 expression. Following acute treatment (6 h) with GGA, HLMVECs exposed to PLY displayed improved cell viability and enhanced endothelial barrier function as measured by both Electric Cell-substrate Impedance Sensing (ECIS) and transwell permeability assays compared to control treated cells. PLY promoted increased mitochondrial ROS, decreased mitochondrial oxygen consumption, and increased caspase 3 cleavage and cell death, which were collectively improved in cells pretreated with GGA. In mice, IP pretreatment with GGA 24 h prior to IT administration of PLY resulted in significantly less Evans Blue Dye extravasation compared to vehicle, indicating preserved endothelial barrier integrity and suggesting that the acute upregulation of Hsp70 may be an effective therapeutic approach in the treatment of lung injury associated with pneumonia.

Highlights

  • Pneumonia is a pulmonary infection that can affect people of all ages, but is most severe in the elderly, children, and the immunocompromised

  • To determine the effect of Hsp70 on barrier function, Human lung microvascular endothelial cells (HLMVECs) were transduced with adenoviruses encoding Hsp70 or GFP (Control, 60MOI) overnight and transferred to an ECIS plate

  • HLMVECs transduced with the Hsp70 adenovirus were significantly protected from PLY-induced barrier dysfunction as compared to control cells (Figure 1A)

Read more

Summary

Introduction

Pneumonia is a pulmonary infection that can affect people of all ages, but is most severe in the elderly, children, and the immunocompromised. Upon binding to cholesterol molecules on the cell membrane of target cells, PLY induces the macromolecular assembly of ring shaped pores that promote calcium influx and alter intracellular signaling [9, 10]. Subsequent to these changes, G+-toxins robustly increase the intracellular production of reactive oxygen species (ROS) [6, 7, 11,12,13]. NADPH-derived ROS have been shown to promote oxidative damage of mitochondrial proteins in complex I and complex II, which results in increased mitoROS production [20]. ROS can deplete BH4 and alter the S-glutathionylation of eNOS, compromising NO formation and increasing ROS production [24, 25]

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.